HGH Holdings Ltd. (SGX:5GZ)
Singapore · Delayed Price · Currency is SGD 0.0190
-0.0010 (-5.00%)
At close: Aug 14, 2026
HGH Holdings Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 76.48 | 54.64 | 21.32 | 20.03 | 21.59 | 20.07 | |
Revenue Growth | 107.01% | 156.33% | 6.41% | -7.20% | 7.56% | 71.60% |
Cost of Revenue | 57.33 | 40.69 | 15.24 | 16.25 | 17.75 | 15.52 |
Gross Profit | 19.15 | 13.95 | 6.08 | 3.78 | 3.84 | 4.55 |
Selling, General & Admin | 8.71 | 7.51 | 5.99 | 5.49 | 6.25 | 5.99 |
Other Operating Expenses | 0.01 | 0.01 | 0.03 | 0.01 | 0.11 | 0.94 |
Operating Expenses | 9.15 | 7.95 | 6.33 | 5.43 | 6.21 | 7.26 |
Operating Income | 10.01 | 6 | -0.25 | -1.65 | -2.38 | -2.71 |
Interest Expense | -0.48 | -0.37 | -0.28 | -0.16 | -0.17 | -0.17 |
Interest & Investment Income | 0.02 | 0.02 | 0.08 | 0.13 | - | - |
Currency Exchange Gain (Loss) | -0 | -0 | 0.04 | -0.04 | -0.05 | - |
Other Non Operating Income (Expenses) | 0.49 | 0.43 | 0.2 | 1.08 | 0.59 | 0.36 |
EBT Excluding Unusual Items | 10.03 | 6.07 | -0.21 | -0.64 | -2 | -2.52 |
Gain (Loss) on Sale of Assets | 0.01 | 0.01 | - | 0.03 | 0.22 | 0.14 |
Asset Writedown | - | - | -0.13 | - | - | -1.01 |
Other Unusual Items | - | - | - | - | - | 0.37 |
Pretax Income | 10.04 | 6.09 | -0.33 | -0.61 | -1.78 | -3.02 |
Income Tax Expense | 1.49 | 0.89 | -0.1 | -0.28 | -0.27 | -0.73 |
Earnings From Continuing Operations | 8.56 | 5.2 | -0.23 | -0.32 | -1.51 | -2.29 |
Net Income to Company | 8.56 | 5.2 | -0.23 | -0.32 | -1.51 | -2.29 |
Minority Interest in Earnings | -0.48 | 0.02 | 0.03 | 0.02 | 0.01 | 0.02 |
Net Income | 8.07 | 5.22 | -0.2 | -0.31 | -1.5 | -2.27 |
Net Income to Common | 8.07 | 5.22 | -0.2 | -0.31 | -1.5 | -2.27 |
Net Income Growth | 226.27% | - | - | - | - | - |
Shares Outstanding (Basic) | 1,795 | 1,781 | 1,781 | 1,781 | 1,781 | 1,781 |
Shares Outstanding (Diluted) | 1,795 | 1,781 | 1,781 | 1,781 | 1,781 | 1,781 |
Shares Change | 5.04% | - | - | - | - | - |
EPS (Basic) | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS Growth | 210.64% | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.55 | -3.06 | -2.57 | 2.71 | -0.3 | 1.75 |
Free Cash Flow Per Share | - | -0.00 | -0.00 | 0.00 | - | 0.00 |
Gross Margin | 25.04% | 25.53% | 28.51% | 18.87% | 17.77% | 22.69% |
Operating Margin | 13.08% | 10.98% | -1.16% | -8.23% | -11.00% | -13.50% |
Profit Margin | 10.55% | 9.55% | -0.94% | -1.53% | -6.97% | -11.32% |
Free Cash Flow Margin | 0.72% | -5.60% | -12.06% | 13.53% | -1.41% | 8.70% |
EBITDA | 15.06 | 10.74 | 3.4 | 1.93 | 1.32 | 1.76 |
EBITDA Margin | 19.69% | 19.65% | 15.96% | 9.61% | 6.10% | 8.78% |
D&A For EBITDA | 5.05 | 4.73 | 3.65 | 3.57 | 3.69 | 4.47 |
EBIT | 10.01 | 6 | -0.25 | -1.65 | -2.38 | -2.71 |
EBIT Margin | 13.08% | 10.98% | -1.16% | -8.23% | -11.00% | -13.50% |
Effective Tax Rate | 14.79% | 14.60% | - | - | - | - |